Skip to main navigation Skip to search Skip to main content

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations

Research output: Contribution to journalArticlepeer-review

Abstract

<p> Randomization is the foundation of any randomized controlled trial involving treatment comparisons. The major benefits of randomization in the context of clinical trials are: <ul> <li> Randomization helps mitigate various experimental biases. </li> <li> It promotes comparability of treatment groups with respect to important known and unknown prognostic factors that may be correlated with the primary outcome. </li> <li> It is the basis for the validity of standard statistical tests and makes the underlying assumptions of random sampling more plausible. </li> <li> It can form the basis for statistical inference through re-randomization tests. </li> </ul></p>
Original languageAmerican English
JournalLinkedIn
StatePublished - Apr 28 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Biostatistics
  • Environmental Public Health
  • Epidemiology
  • Public Health

Fingerprint

Dive into the research topics of 'Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations'. Together they form a unique fingerprint.

Cite this